Related Experiment Video
Updated: Apr 20, 2026

In Vitro Model of Coronary Angiogenesis
Published on: March 10, 2020
Antiangiogenic VEGF-A in peripheral artery disease
Joshua M Boucher1, Victoria L Bautch2
1Department of Biology and the Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Abstract:
Vascular endothelial growth factor A (VEGF-A) is a potent proangiogenic cytokine elevated in patients with peripheral artery disease (PAD). A new study links impaired vascular regrowth in PAD to increased expression of an antiangiogenic splice variant of VEGF-A.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease IV: Nursing Management
Mechanism of Angiogenesis

